Skip to content
Clinical Trials – home

Azienda Socio Sanitaria Territoriale Della Valle Olona

Verifiedinfo

Italy Piazza Don Giuseppe Borella 1, 21047 Saronno, Italy

  • 13 trials recruiting
  • Atrial fibrillation · Follicular lymphoma · Non-small cell lung cancer
  • Adults and children

About Specializations

Azienda Socio Sanitaria Territoriale Della Valle Olona in Saronno, Italy specialises in clinical trials of conditions such as Atrial fibrillation, Follicular lymphoma, Non-small cell lung cancer, Multiple sclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases and Traumatic Brain Injury Research

At Azienda Socio Sanitaria Territoriale Della Valle Olona in Saronno, the Neuroscience department is involved in clinical research focused on nervous system diseases, with a strong emphasis on subacute moderate to severe traumatic brain injury. These studies are designed to assess the safety and tolerability of a new treatment approach and to explore its potential to support recovery in adults with brain injury.

  • Study of traumatic brain injury care in adults with moderate to severe injury
  • Evaluation of a new intranasal therapy for safety, tolerability, and possible clinical benefit
  • Research aimed at improving treatment options in neurorehabilitation

This work reflects a small but focused effort to advance neurologic care through early clinical testing and better understanding of treatment effects.

Nutritional and Metabolic Diseases in Chronic Dialysis Care

The site is also conducting research in nutritional and metabolic diseases, centered on end stage kidney disease in people receiving chronic dialysis therapy. The trial is examining whether a potassium-binding treatment can help patients reduce strict dietary potassium limits without increasing the risk of hyperkalemia, while also looking at quality of life and nutrition.

  • End stage kidney disease in patients on chronic dialysis
  • Assessment of a treatment intended to support safer potassium control
  • Interest in improving dietary flexibility, nutrition, and patient well-being

At this hospital/clinic, the research combines kidney care and nutrition-focused outcomes to better understand how treatment may improve everyday management for dialysis patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Piazza Don Giuseppe Borella 121047 SaronnoItaly
Recruiting now
13 trials
Conditions studied
24
Partner status
Verified

More sites in SaronnoItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

25 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Sumitomo Pharma America Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Busulfan
  • Sponsor:Medizinische Hochschule Hannover
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Patiromer
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
  • Sponsor:AstraZeneca AB
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Fondazione Italiana Sclerosi Multipla Ente Del Terzo Settore/et S
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Amsacrine
  • Sponsor:Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.

Cardiac failure

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Hamilton Health Sciences Corporation
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Jazz Pharmaceuticals Ireland Limited
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.